NKTR Shares

Nektar Therapeutics (NKTR) EPS is poised to hit -2.41 next quarter: How Investors Can Make It Count the Most?

Zack King

As on Thursday, Nektar Therapeutics (NASDAQ: NKTR) started slowly as it slid -11.47% to $51.12, before settling in for the ...

Nektar Therapeutics (NKTR)’s latest performance is not what we had anticipated

Zack King

Nektar Therapeutics (NASDAQ: NKTR) kicked off on Monday, down -6.29% from the previous trading day, before settling in for the ...

Nektar Therapeutics (NKTR) average volume reaches $994.75K: Is Wall Street expecting a rally?

Steve Mayer

Nektar Therapeutics (NASDAQ: NKTR) on Monday, soared 8.03% from the previous trading day, before settling in for the closing price ...

Nektar Therapeutics (NKTR) is expecting 122.98% growth in the next quarter: What can investors do to maximize their returns?

Steve Mayer

On Monday, Nektar Therapeutics (NASDAQ: NKTR) was 5.12% up from the session before settling in for the closing price of ...

Nektar Therapeutics (NKTR) recently have taken one step ahead with the beta value of -1.05

Steve Mayer

Nektar Therapeutics (NASDAQ: NKTR) flaunted slowness of -6.45% at $53.95, as the Stock market unbolted on Thursday, before settling in ...

Nektar Therapeutics (NKTR) kicked off at the price of $59.92: Venture capitalists have an exciting new opportunity

Sana Meer

On Monday, Nektar Therapeutics (NASDAQ: NKTR) was -7.72% drop from the session before settling in for the closing price of ...

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.